Journalist Hunt

JournalistsPricingBlogs
LoginSign up

Stanton R. Mehr - Profile and Journalist Details

Find journalists that align with your industry, location and vision. Unlock Stanton R. Mehr's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.

Get connected with journalists today
Stanton R. Mehr

Stanton R. Mehr

Verified

Principal, Biosimilars Review & Report

Philadelphia

Beats

Primary beats

Health

Secondary beats

Mental health awarenessCrimePC GamingWomen in STEMConventions and conferencesPersonal GrowthMental HealthHealthcareEntertainmentOutdoorsPublic Health InitiativesFamily fun and activitiesFilm and TVShowbizEnvironment and educationWomen Empowerment

Final Covers

Space , Animals, Health , Biology, Environment, Science

Doesn’t Cover

Journalist Type

Journalist

Seniority Positions

Principal

Industries

Content

Total articles 172

  • Biosimilar Bytes: Eculizumab Biosimilar Launches, Rights to Actemra Biosimilar Sold, and New Biosimilar Bevacizumab Approved

    By Stanton R. Mehr

    Apr. 10, 2025

  • Biosimilar Hearings Day in Congress

    By Stanton R. Mehr

    Apr. 09, 2025

  • Biosimilar Bytes: Eculizumab Biosimilar Launches, Rights to Actemra Biosimilar Sold, and New Biosimilar Bevacizumab Approved

    By Stanton R. Mehr

    Apr. 10, 2025

As seen in

Springer,American Journal Of Managed Care,Life Science Leader,Pharmaceutical Executive,Bioprocess Online,Biosimilars Review & Report,Biosimilar Development,Onclive

Company Info

Biosimilars Review & Report

Biosimilars Review & Report (BR&R) provides education, commentary, and updates on the US biosimilar marketplace, including a free, updated database on all 351(k) biologic licensing applications to the FDA.

, ,

Founded: 2014